View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 13, 2022

GE Healthcare to invest in Pulsenmore to enter homecare segment

GE will collaborate with Pulsenmore to supply its products in Europe and various other markets.

GE Healthcare has signed an agreement to invest up to $50m in Israeli start-up PulseNmore and enter the homecare segment facilitating precision health. 

Free Report
img

How attractive are current investment opportunities in Europe?

Europe has been identified as one of the most favorable regions for investors, seeing high investment activity in the past year. Most of these investments have been through Debt Offering, valued at close to $700 billion. The region has provided attractive investments in a diverse set of companies. Companies who tend to major themes such Digital Media, Cloud, Artificial Intelligence, E-commerce, and Big Data are recording the highest number of deals, with Digital Media recording close to 2,000 deals. However, GlobalData’s whitepaper offers a full view of the market, analyzing less successful or attractive points of investment as well, examining statistics on Equity Offering investments and PE/VC deals. Understand how government agencies for economies around the world use GlobalData Explorer to:  
  • Track the M&A and Capital Raising volumes into their target market
  • Identify the top sectors in the target market attracting the investments
  • For any investment segment, identify the top Investors inside and outside the target economy that are already investing in the Segment
  • Assess and showcase the growth potential for various Industries in the target economy
Don’t miss out on key market insights that can help optimize your next investment – read the report now.
by GlobalData
Enter your details here to receive your free Report.

The equity investment is intended to expedite the international acceptance of the homecare ultrasound solutions from PulseNmore

It will also support receipt of US Food and Drug Administration (FDA) approval and commercial expansion. 

Apart from the investment, GE will collaborate with PulseNmore to supply its products in Europe and various other markets once the product becomes commercially available.

Furthermore, the companies will partner to develop ultrasound-based healthcare offerings intended for the growing homecare market.

With its new self-operated prenatal home ultrasound solution, PulseNmore is ideally positioned for the telehealth market.

On connecting to a smartphone, the solution allows pregnant women to perform self-scanning for remote clinical analysis by their healthcare provider.

A handheld ultrasound device that can be attached to the user’s smartphone and a mobile app that aids the patient in consulting a clinician in offline/online mode are included in the product offering.

The offering also includes a web application for clinician-side interaction with the platform and a software API that facilitates merging the company’s online services with health records.

The PulseNmore device offers regular fetal ultrasound scanning and consultation as an offline application-guided service or online clinician-guided telecommunication service.

PulseNmore CEO and founder Dr Elazar Sonnenschein said: “With GE Healthcare ’s market leadership position and reach, we are one step closer to achieving our vision of making home ultrasound universally accessible for remote and reliable care, ultimately improving maternal health across the globe. 

“Through this exciting partnership, we will accelerate the empowerment of women to proactively manage their pregnancy, in collaboration with their health care providers, and will lead the next wave of ultrasound innovation that will benefit patients and providers alike.”

The company is developing various other applications and devices, including remote follicular monitoring for women who undergo in-vitro fertilisation and remote monitoring for end-stage renal disease and chronic heart failure. 

Last December, GE Healthcare concluded the acquisition of surgical visualisation company BK Medical for $1.45bn in cash.

Related Companies

Free Report
img

How attractive are current investment opportunities in Europe?

Europe has been identified as one of the most favorable regions for investors, seeing high investment activity in the past year. Most of these investments have been through Debt Offering, valued at close to $700 billion. The region has provided attractive investments in a diverse set of companies. Companies who tend to major themes such Digital Media, Cloud, Artificial Intelligence, E-commerce, and Big Data are recording the highest number of deals, with Digital Media recording close to 2,000 deals. However, GlobalData’s whitepaper offers a full view of the market, analyzing less successful or attractive points of investment as well, examining statistics on Equity Offering investments and PE/VC deals. Understand how government agencies for economies around the world use GlobalData Explorer to:  
  • Track the M&A and Capital Raising volumes into their target market
  • Identify the top sectors in the target market attracting the investments
  • For any investment segment, identify the top Investors inside and outside the target economy that are already investing in the Segment
  • Assess and showcase the growth potential for various Industries in the target economy
Don’t miss out on key market insights that can help optimize your next investment – read the report now.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network